Europe Factors-Shares seen down ahead of ECB's decision
(Adds details, futures, company news; update snapshot)
PARIS, Sept 3 (Reuters) - European equities were seen falling for a fourthstraight session on Thursday, tracking a dip on Wall Street where a poor labourmarket report rattled investors ahead of Friday's key jobs figures.
By 0624 GMT, futures for the DJ Euro Stoxx STXEc1, for Germany's DAXFDXc1 and for France's CAC FCEc1 were down between 0.05 percent and 0.2percent. Earlier, financial spreadbetters had expected Britain's FTSE 100.FTSE to open 12 to 18 points lower, or down as much as 0.4 percent.
Investors were also cautious ahead of the European Central Bank's decisionon interest rates and comments on the outlook for the economy.
The ECB is expected to keep interest rates at 1.0 percent, and PresidentJean-Claude Trichet is likely to preach caution on the growing hype of a speedyeuro zone economic rebound from recession. [ID:nL2620882]
U.S. stocks retreated on Wednesday after a labour market report showed moreprivate sector job losses in August than forecast. That rattled investors aheadof Friday's key monthly jobs data from the U.S. Labour Department.
The FTSEurofirst 300 .FTEU3 index of top European shares fell 0.4 percenton Wednesday, with financial stocks suffering the most, as investors tookprofits after a strong run in recent months. Europe's benchmark index, which hassurged 47 percent from the record low it hit in March, is up 14 percentyear-to-date.
----------------------MARKET SNAPSHOT AT 0622 GMT----------------------
LAST PCT CHG NET CHG
S&P 500 .SPX 994.75 -0.33 % -3.29
NIKKEI .N225 10,214.64 -0.64 % -65.82
MSCI ASIA EX-JP .MIASJ0000PUS 424.56 1.01 % 4.24
EUR/USD EUR= 1.4284 0.14 % 0.0020
USD/JPY JPY= 92.38 0.17 % 0.1600
10-YR US TSY YLD US10YT=RR 3.331 -- 0.02
10-YR BUND YLD EU10YT=RR 3.238 -- 0.02
SPOT GOLD XAU= $976.85 0.03 % $0.25
US CRUDE CLc1 $68.43 0.56 % 0.38
-----------------------------------------------------------------------
* Wall St ends down for 4th day; caution prevails [ID:nL3307903]
* GLOBAL MARKETS-Japan stocks dip on US job uncertainty [ID:nSP520876]
* Nikkei slips 0.6 pct as stronger yen hits exporters [ID:nT16460]
* China stocks rise 3 pct as regulator assures market [ID:nBJD002992]
* TREASURIES-Prices up on view econ. recovery will be subdued [ID:nL3308066]
* Oil steady above $68 on neutral U.S. stocks data [ID:nSIN540872]
* Yen retreats from 7-wk high vs dlr on China shares [ID:nT237044]
* Shanghai copper up 1 pct, LME eases on data [ID:nSP379442]
* Gold inches down on profit-taking, eyes on G20 [ID:nT237725]
COMPANY NEWS:
PERNOD RICARD (PERP.PA)
French spirits group Pernod Ricard posted a 21 percent rise in fiscalfull-year profit from recurring operations, broadly in line with expectations,boosted by growth in France, Asia and Latin America. For more, double click on[ID:L3320454]
EADS (EAD.PA) (EAD.DE)
In a victory for Boeing (BA.N), a preliminary World Trade Organization panelis likely to rule on Friday that European governments illegally subsidizedAirbus aircraft, the Wall Street Journal said, citing trade officials, lawyersand executives from both sides. For details, see: [ID:nBNG412677]
CREDIT SUISSE (CSGN.VX)
Credit Suisse Group AG named Eric Varvel acting chief executive of itsbooming investment bank on Wednesday due to the "sudden and unexpected illness"of incumbent Paul Calello. For related news click on [CSGN.VX-LEN-RTRS]
UBS (UBSN.VX)
Canadian government officials pressed representatives of Swiss bank UBS onWednesday for details of Canadians who might be account holders, a spokeswomanfor the Canada Revenue Agency said. For related news click on [UBSN.VX-LEN-RTRS]
ROCHE HOLDINGS AG (ROG.VX)
The European Commission has approved Roche's MabThera cancer drug to treatpatients whose chronic lymphocytic leukaemia (CLL) returns, the Swiss drugmakersaid. For related news click on [ROG.VX-LEN-RTRS]
NOVARTIS (NOVN.VX)
A pilot trial with Novartis AG's adjuvanted cell culture-based vaccine forH1N1 flu shows a strong immune response, even after one dose, the Swissdrugmaker said. For related news click on [NOVN.VX-LEN-RTRS]
RWE (RWEG.DE)
Germany's second-largest utility has agreed to pay 950 million euros ($1.35billion) less to buy the Dutch utility Essent, an Essent spokesman said onWednesday. The deal between RWE and Essent excludes the Borssele nuclear plant,the spokesman added. The purchase price should now be around 7.25 billion euros.Related news [RWEG.DE-LEN-RTRS]
ACCIONA (ANA.MC) IBERDROLA (IBE.MC)
The construction, energy and water conglomerate and Spain's largest utilitycould receive $200 million in US state aid to renewable energy from the secondphase of the Obama administration's subsidy program, Cinco Dias reported withoutciting a source.
BAYER AG (BAYG.DE)
The drug and chemicals company acquired two prescription dermatologyproduct lines from SkinMedica in the United States, but did not disclose apurchase price or expected revenues. Under the agreement, Bayer will acquire allcommercial rights, including assigned contracts and intellectual propertyrelated to the two product lines. Related news [BAYG.DE-LEN-RTRS]
ATOS ORIGIN (ATOS.PA)
French IT services group Atos Origin is in advanced talks to buy Italianelectronic payment company SIA-SSB, La Tribune reported. An Atos spokeswomandeclined to comment. For details, see: [ID:nB141432]
ENI (ENI.MI)
The oil and gas group is in talks with small shareholder Knight Vinke afterthe fund called for changes in Eni's business structure, Eni said on Wednesday.[ID:nL2729227]
(Reporting by Blaise Robinson)
Source: Reuters


